Literature DB >> 21220216

KPC-2 carbapenemase-producing Klebsiella pneumoniae isolates from patients with Cystic Fibrosis.

Robson S Leão1, Rosana H V Pereira, Tânia W Folescu, Rodolpho M Albano, Erica A Santos, Luiz G C Junior, Elizabeth A Marques.   

Abstract

Bacteria producing Klebsiella pneumoniae carbapenemases (KPCs) are rapidly emerging as a cause of multidrug-resistant infections worldwide. KPCs enzyme are plasmid-borne and can accumulate and transfer resistance determinants to other classes of antibiotics.We report two cases of KPC-2 carbapenemase-producing Klebsiella pneumoniae isolates from Cystic Fibrosis patients.
Copyright © 2010 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21220216     DOI： 10.1016/j.jcf.2010.12.003

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN： 1569-1993            Impact factor:   5.482


  6 in total

1.  Carbapenem-Resistant Pseudomonas aeruginosa in Chronic Lung Infection: Current Resistance Profile and Hypermutability in Patients with Cystic Fibrosis.

Authors:  Mila M Almeida; Meyvianne T Freitas; Tania W Folescu; Monica C Firmida; Ana Paula D'A Carvalho-Assef; Elizabeth A Marques; Robson S Leão
Journal:  Curr Microbiol       Date:  2021-01-06       Impact factor: 2.188

2.  First report of chronic pulmonary infection by KPC-3-producing and colistin-resistant Klebsiella pneumoniae sequence type 258 (ST258) in an adult patient with cystic fibrosis.

Authors:  Emanuele Delfino; Daniele Roberto Giacobbe; Valerio Del Bono; Erika Coppo; Anna Marchese; Graziana Manno; Patrizia Morelli; Laura Minicucci; Claudio Viscoli
Journal:  J Clin Microbiol       Date:  2015-02-04       Impact factor: 5.948

Review 3.  Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Authors:  L S Tzouvelekis; A Markogiannakis; M Psichogiou; P T Tassios; G L Daikos
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

4.  Antimicrobial Susceptibility of Pseudomonas aeruginosa Isolated from Cystic Fibrosis Patients in Northern Europe.

Authors:  Muhammad-Hariri Mustafa; Hussein Chalhoub; Olivier Denis; Ariane Deplano; Anne Vergison; Hector Rodriguez-Villalobos; Michael M Tunney; J Stuart Elborn; Barbara C Kahl; Hamidou Traore; Francis Vanderbist; Paul M Tulkens; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

5.  Enterobacter cloacae harbouring blaKPC-2 and qnrB-1 isolated from a cystic fibrosis patient: a case report.

Authors:  D P Alves; A P D'A Carvalho-Assef; O C Conceição-Neto; C A M Aires; R M Albano; T W Folescu; S C S Ornelas; R S Leão; E A Marques
Journal:  New Microbes New Infect       Date:  2018-07-06

Review 6.  Antimicrobial resistance in Enterobacteriaceae in Brazil: focus on β-lactams and polymyxins.

Authors:  Jorge Luiz Mello Sampaio; Ana Cristina Gales
Journal:  Braz J Microbiol       Date:  2016-10-25       Impact factor: 2.476
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.